Recombinant Anti-CD3 x Anti-GD2 Bispecific Antibody (VHH-IgG) is formed by an IgG and two VHH fragments. The VHHs from an anti-GD2 antibody variable domain are respectively connected to the N terminus of the anti-CD3 IgG heavy chains or light chains to form VHH-(H)IgG or VHH-(L)IgG. It is a type of appended IgGs and has 2+2 antigen-binding valency. This BsAb can retarget T cells to tumor cells. It is designed for the research of Neuroblastoma; Osteosarcoma; Melanoma; Solid tumors therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-GD2 Bispecific Antibody (VHH-IgG) (BSSG-378). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS